FDA Inspection 1301534 - Axsome Therapeutics, Inc. - February 06, 2026

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Axsome Therapeutics, Inc., with an inspection on February 6, 2026, issued by the New York District Office, covering human drugs.

Company: Axsome Therapeutics, Inc.
Inspection Date: February 6, 2026
Product Type: Human Drugs
Office: New York District Office

Open in Dashboard

ID · d755cc61-e3b0-4906-a414-dc235848df39

Violation Codes2

21 CFR 312.5021 CFR 312.56(b)

Full citation text and observation details available on the Dashboard.